CSL has made a great FDA success as show below. Not IMU but posted out of interest.
Quote - "Australian biotech giant CSL will bring the first gene therapy for haemophilia B to market in the United States after gaining regulatory approval for a new drug called Hemgenix. CSL confirmed on Wednesday that the US Food and Drug Administration has granted approval for the therapy, which it has been developing since inking a deal worth $US655 million with US biotech UniQure back in 2020.
Because gene therapies are designed as one-off treatments that replace regular treatments across a patient’s lifetime, they often come with steep price tags. CSL will list Hemgenix at $US3.5 million ($5.3 million), making it one of the most expensive single treatments in the history of the United States."
Media Thread, page-7568
-
- There are more pages in this discussion • 7,636 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.3¢ |
Change
0.001(0.96%) |
Mkt cap ! $382.1M | |||
| Open | High | Low | Value | Volume |
| 5.2¢ | 5.4¢ | 5.2¢ | $182.5K | 3.455M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 34 | 1850568 | 5.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.3¢ | 315781 | 11 |
View Market Depth
| Last trade - 13.03pm 26/08/2024 (20 minute delay) ? |
| IMU (ASX) Chart |